Frontiers
US$ 27.14
subcutaneous ghk cu clinical trial human Frontiers The Human Tripeptide GHK-Cu in
Description
2014;4:e005090
The cycle structure exists for a practical reason: continuous stimulation of the same receptor pathways can lead to reduced sensitivity over time, and a rest period allows the system to reset before the next cycle produces full effect
[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Mustafa A.K., Gadalla M.M., Snyder S.H
This peptide is clinically approved and recognized for topical application as a skin rejuvenator [33]
